Parallel Advisors, LLC

Position in AGEN — Agenus Inc

CIK 1690010 SAN FRANCISCO, CA

Position in AGEN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$15

-$1 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#101

of 103 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. AGEN ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15	5	0.0%	Shares	Sole	2026-08-05
2026-03-31	$16	5	0.0%	Shares	Sole	2026-05-07
2025-12-31	$15	5	-79.2%	Shares	Sole	2026-02-11
2025-09-30	$92	24	0.0%	Shares	Sole	2025-11-13
2025-06-30	$109	24	-97.6%	Shares	Sole	2025-07-08
2023-06-30	$1,592	995	-12.5%	Shares	Sole	2024-05-20
2023-03-31	$1,728	1,137	+174.0%	Shares	Sole	2024-05-20
2022-03-31	$1,020	415	0.0%	Shares	Sole	2022-04-28
2021-12-31	$1,336	415	0.0%	Shares	Sole	2022-01-20
2021-09-30	$2,178	415	0.0%	Shares	Sole	2021-11-02
2021-06-30	$2,278	415	0.0%	Shares	Sole	2021-08-06
2021-03-31	$1,128	415	0.0%	Shares	Sole	2021-04-23
2020-12-31	$1,319	415	0.0%	Shares	Sole	2021-02-02
2020-09-30	$1,659	415	0.0%	Shares	Sole	2020-10-27
2020-06-30	$1,630	415	0.0%	Shares	Sole	2020-07-16
2020-03-31	$1,016	415	—	Shares	Sole	2020-04-27
No filing history on record for this holder in this stock.